Home » Topics » BioWorld Science

BioWorld Science
RSS

JCR initiates phase II trial of JR-142 in pediatric patients with growth hormone deficiency

May 19, 2021

Phase I data on SLN-124 support ongoing evaluation in patients with thalassemia and MDS

May 19, 2021

Veru advances VERU-111 into phase III for treatment of COVID-19

May 19, 2021

CoVac-1, a COVID-19 vaccine useful for cancer patients undergoing B-cell depleting therapy

May 19, 2021

NADI-351 shows significant antitumor activity and low toxicity in xenograft models

May 19, 2021

Applied Genetic Technologies patents new AAV vectors

May 19, 2021

Eccogene (Shanghai) identifies SSAO inhibitors

May 19, 2021

Inhibition of CAMK1D restores sensitivity in PD-L1 refractory tumors

May 19, 2021

Amgen synthesizes GTPase KRAS mutant inhibitors

May 19, 2021

Medshine Discovery discloses xanthine oxidase inhibitors

May 19, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...